Thanksgiving is just a few days away, so I thought it would be a good time to repeat a few of my airline travel tips and add a few new ones. Get the wait-time app Needless to say, you need to get to the airport early on busy travel days. How early? In the United […] The post Airport Tips for Holiday Flyers appeared first on Multiple Sclerosis News Today.
U.S. nurses and physicians’ assistants prescribe antibody-based disease-modifying therapies to their multiple sclerosis patients more than neurologists do, a survey indicates. The trend has been for the doctors to stick with interferon therapies, the study said. Show More Summary
Anniversaries often invoke reflection about the beginning, the journey, and where we now find ourselves. With luck, lessons will have been learned from the invariably good and bad experiences that couple any passage of time. In November 2010, I sat, eyes firmly affixed, as my neurologist read my MRI results. Show More Summary
There is often alarm and confusion about the JC virus, how we get it, and what it means to people with multiple sclerosis. This is my quick primer to help address these questions in a very basic way. What is the JC virus? The first person identified with this virus was named John Cunningham. In […] The post A JC Virus Primer appeared first on Multiple Sclerosis News Today.
Multiple sclerosis (MS) patients being treated with dronabinol, a cannabinoid, do not show signs of drug abuse or dependency, leading researchers to conclude it has potential to be a long-term and safe treatment option for neuropathic pain. Show More Summary
A pregnancy hormone called estriol may be effective in controlling relapses in women with multiple sclerosis (MS), says a researcher at the University of California, Los Angeles (UCLA). In clinical trials, estriol has also lowered fatigue and improved thinking — work that originated in Rhonda Voskuhl’s quest to understand sex differences in MS. Show More Summary
Face it: Understanding MS isn’t easy — even if you have it. There’s no known cause, no cure, no predictability in progression, and while there are common symptoms and manifestations, they affect everyone differently. Some symptoms come...Show More Summary
Severe fatigue, brain fog, unintended weight loss and vision loss were some of the symptoms that would ultimately lead to my diagnosis of relapsing remitting multiple sclerosis (RRMS). In May 2010 at the age of 18, I was referred by a local neurologist to a specialist at UCSF Medical Center. Show More Summary
Results from two phase 3 trials evaluating the efficacy and safety of the drug ozanimod have now been released.
In the fall of 1976, I was a high school freshman. I took a radio class with some upper classmen that included a cute little redhead. She was a junior with beautiful green eyes, a pretty smile and a great laugh. A few months later we were together on New Year’s Eve, and we shared a short and somewhat surprising kiss at midnight. Show More Summary
About five years ago, I was tucking my son in for bed one night. I turned off the lights, turned on the ceiling fan (it’s a Texas thing) and kneeled near his bed so we could say our prayers. After we finished, I gave him a hug, told him I loved him and as I stood to walk out, he asked, “Daddy, what are you going to dream about?”...
?It’s been a real energy boost to attend this conference and to feel the buzz of 10,000 people talking about the latest groundbreaking MS research. The topic of emerging therapies is near and dear to me, since I work on the researchShow More Summary
A breakthrough study has revealed unique molecules in the blood of people with Multiple Sclerosis (MS) that could become definitive diagnostic biomarkers of the world's most common neurologic disability in young adults. The discovery...Show More Summary
MSPARIS2017 is a remarkable event—it’s a spectacular gathering of thousands of professionals who are dedicated to the treatment and research of MS. I am especially encouraged by the growing number and diversity of presentations on an...Show More Summary